Latest News
Stay up to date on news, events, and other items of interest to our AN community.
- Details
There are no FDA-approved drug therapies for vestibular schwannoma (VS), the fourth most common intracranial tumor. In a study published this Wednesday in Scientific Reports, researchers from Massachusetts Eye and Ear have identified a set of genes that are consistently and abnormally expressed in this tumor as compared to control nerves. Rather than use this information to develop a new compound that can stop VS cells from growing, the researchers were interested in computationally probing the known genetic effects of drugs already approved for human use.
- Details
Notes Newsletter March Issue Online Now!
The March 2018 issue of Notes is now available in the ANA Member Section of our website. In this issue:
- Details
January is Support Group Awareness Month.
Is a Support Group For Me?
ANA Support Group - FAQs
Thank you to the many ANA members who attend support group meetings and to the ANA volunteers who make these opportunities possible. “Support Group” does not fully describe the extent of the what groups provide.
- Details
The sixth annual ANAwareness Week is May 6-12, 2018.
The Acoustic Neuroma Association invites you to raise awareness of acoustic neuroma and of the challenges and accomplishments of AN patients. As we continue our preparations for this special week, there are a few things you can do now to get started.
READ MORE
- Details
Please join us for a Facebook Live event on January 16th at 7pm ET to discuss Neurofibromatosis 2 (NF2). These tumors, also known as acoustic neuromas or vestibular schwannomas, occur bilaterally (on both sides).
